Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles

被引:97
作者
Boros, Eszter [1 ,2 ]
Bowen, Alice M. [3 ]
Josephson, Lee [4 ]
Vasdev, Neil [2 ,5 ]
Holland, Jason P. [2 ,5 ]
机构
[1] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA 02114 USA
[3] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, Ctr Biomol Magnet Resonance BMRZ, D-60438 Frankfurt, Germany
[4] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Adv Mol Imaging Sci, Charlestown, MA 02129 USA
[5] Massachusetts Gen Hosp, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA
基金
瑞士国家科学基金会;
关键词
MR CONTRAST AGENTS; IN-VIVO; CANCER-THERAPY; PHYSICOCHEMICAL PROPERTIES; MAGNETIC NANOPARTICLES; CARBON NANOTUBES; DELIVERY; DEXTRAN; DRUGS; ZR-89-TRANSFERRIN;
D O I
10.1039/c4sc02778g
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
A novel reaction for chelate-free, heat-induced metal ion binding and radiolabeling of ultra-small paramagnetic iron oxide nanoparticles (USPIOs) has been established. Radiochemical and non-radioactive labeling studies demonstrated that the reaction has a wide chemical scope and is applicable to p-, d- and f-block metal ions with varying ionic sizes and formal oxidation states from 2+ to 4+. Radiolabeling studies found that Zr-89-Feraheme (Zr-89-FH or Zr-89-ferumoxytol) can be isolated in 93 +/- 3% radiochemical yield (RCY) and >98% radiochemical purity using size-exclusion chromatography. Zr-89-FH was found to be thermodynamically and kinetically stable in vitro using a series of ligand challenge and plasma stability tests, and in vivo using PET/CT imaging and biodistribution studies in mice. Remarkably, ICP-MS and radiochemistry experiments showed that the same reaction conditions used to produce Zr-89-FH can be employed with different radionuclides to yield Cu-64-FH (66 +/- 6% RCY) and In-111-FH (91 +/- 2% RCY). Electron magnetic resonance studies support a mechanism of binding involving metal ion association with the surface of the magnetite crystal core. Collectively, these data suggest that chelate-free labeling methods can be employed to facilitate clinical translation of a new class of multimodality PET/MRI radiotracers derived from metal-based nanoparticles. Further, this discovery is likely to have broader implications in drug delivery, metal separation science, ecotoxicology of nanoparticles and beyond.
引用
收藏
页码:225 / 236
页数:12
相关论文
共 49 条
[1]
Positron Emitting Magnetic Nanoconstructs for PET/MR Imaging [J].
Aryal, Santosh ;
Key, Jaehong ;
Stigliano, Cinzia ;
Landis, Melissa D. ;
Lee, Daniel Y. ;
Decuzzi, Paolo .
SMALL, 2014, 10 (13) :2688-2696
[2]
Physicochemical properties of ferumoxytol, a new intravenous iron preparation [J].
Balakrishnan, V. S. ;
Rao, M. ;
Kausz, A. T. ;
Brenner, L. ;
Pereira, B. J. G. ;
Frigo, T. B. ;
Lewis, J. M. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (06) :489-496
[3]
BIODISTRIBUTION OF AN ULTRASMALL SUPERPARAMAGNETIC IRON-OXIDE COLLOID, BMS-180549, BY DIFFERENT ROUTES OF ADMINISTRATION [J].
BENGELE, HH ;
PALMACCI, S ;
ROGERS, J ;
JUNG, CW ;
CRENSHAW, J ;
JOSEPHSON, L .
MAGNETIC RESONANCE IMAGING, 1994, 12 (03) :433-442
[4]
Intrinsically Germanium-69-Labeled Iron Oxide Nanoparticles: Synthesis and In-Vivo Dual-Modality PET/MR Imaging [J].
Chakravarty, Rubel ;
Valdovinos, Hector F. ;
Chen, Feng ;
Lewis, Christina M. ;
Ellison, Paul A. ;
Luo, Haiming ;
Meyerand, M. Elizabeth ;
Nickles, Robert J. ;
Cai, Weibo .
ADVANCED MATERIALS, 2014, 26 (30) :5119-5123
[5]
Chelator-Free Synthesis of a Dual-Modality PET/MRI Agent [J].
Chen, Feng ;
Ellison, Paul A. ;
Lewis, Christina M. ;
Hong, Hao ;
Zhang, Yin ;
Shi, Sixiang ;
Hernandez, Reinier ;
Meyerand, M. Elizabeth ;
Barnhart, Todd E. ;
Cai, Weibo .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (50) :13319-13323
[6]
A Magnetofluorescent Nanoparticle for Ex-Vivo Cell Labeling by Covalently Linking the Drugs Protamine and Feraheme [J].
Chen, Suelin ;
Alcantara, David ;
Josephson, Lee .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2011, 11 (04) :3058-3064
[7]
18F Labeled Nanoparticles for in Vivo PET-CT Imaging [J].
Devaraj, Neat K. ;
Keliher, Edmund J. ;
Thurber, Greg M. ;
Nahrendorf, Matthias ;
Weissleder, Ralph .
BIOCONJUGATE CHEMISTRY, 2009, 20 (02) :397-401
[8]
Imaging Tumor Burden in the Brain with 89Zr-Transferrin [J].
Evans, Michael J. ;
Holland, Jason P. ;
Rice, Samuel L. ;
Doran, Michael G. ;
Cheal, Sarah M. ;
Campos, Carl ;
Carlin, Sean D. ;
Mellinghoff, Ingo K. ;
Sawyers, Charles L. ;
Lewis, Jason S. .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (01) :90-95
[9]
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo [J].
Farokhzad, OC ;
Cheng, JJ ;
Teply, BA ;
Sherifi, I ;
Jon, S ;
Kantoff, PW ;
Richie, JP ;
Langer, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (16) :6315-6320
[10]
Nanomedicine: Developing smarter therapeutic and diagnostic modalities [J].
Farokhzad, Omid C. ;
Langer, Robert .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (14) :1456-1459